Metabolic Activity Determines Efficacy of Macroautophagic Clearance of Pathological Oligomeric α-Synuclein
- 31 August 2009
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 175 (2), 736-747
- https://doi.org/10.2353/ajpath.2009.080928
Abstract
No abstract availableKeywords
Funding Information
- Parkinson's Disease Foundation
- National Institutes of Health
- National Institute on Aging (Z01-AG000948)
- National Institute of Neurological Disorders and Stroke (NS050487)
This publication has 71 references indexed in Scilit:
- Association of Glucocerebrosidase Mutations With Dementia With Lewy BodiesArchives of Neurology, 2009
- Aging and dietary restriction effects on ubiquitination, sumoylation, and the proteasome in the heartMechanisms of Ageing and Development, 2008
- Autophagy-mediated clearance of aggresomes is not a universal phenomenonHuman Molecular Genetics, 2008
- Glucocerebrosidase Gene MutationsArchives of Neurology, 2008
- Role of autophagy in G2019S‐LRRK2‐associated neurite shortening in differentiated SH‐SY5Y cellsJournal of Neurochemistry, 2008
- Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's diseaseProceedings of the National Academy of Sciences of the United States of America, 2006
- Suppression of basal autophagy in neural cells causes neurodegenerative disease in miceNature, 2006
- Loss of autophagy in the central nervous system causes neurodegeneration in miceNature, 2006
- α-Synuclein Locus Triplication Causes Parkinson's DiseaseScience, 2003
- α-Synuclein Membrane Interactions and Lipid SpecificityJournal of Biological Chemistry, 2000